Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis

OBJECTIVE: Recent large-scale randomised trials demonstrate that immunomodulators reduce cardiovascular (CV) events among the general population. However, it is uncertain whether these effects apply to rheumatoid arthritis (RA) and if certain treatment strategies in RA reduce CV risk to a greater ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Daniel H, Giles, Jon T, Liao, Katherine P, Ridker, Paul M, Rist, Pamela M, Glynn, Robert J, Broderick, Rachel, Lu, Fengxin, Murray, Meredith T, Vanni, Kathleen, Santacroce, Leah M, Abohashem, Shady, Robson, Philip M, Fayad, Zahi, Mani, Venkatesh, Tawakol, Ahmed, Bathon, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933165/
https://www.ncbi.nlm.nih.gov/pubmed/36450449
http://dx.doi.org/10.1136/ard-2022-223302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933165/
https://www.ncbi.nlm.nih.gov/pubmed/36450449
http://dx.doi.org/10.1136/ard-2022-223302

Ejemplares similares